Company / Cash & Equivalents
KESTRA MEDICAL TECHNOLOGIES, LTD. Cash & Equivalents History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$237.6M
FY2025
5-year range
$8.2M / $237.6M
FY2024-FY2025
Trend
+2780.3%
vs FY2024
Sector context
#73 of 148
Health Care
What the data says
At $238M, KESTRA MEDICAL TECHNOLOGIES, LTD.'s cash & equivalents ranks #73 of 148 in the Health Care sector.
Based on SEC 10-K filings.
$238M in FY2025.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#73 of 148 in Health CareTop 49% of 148This company $237.6M Sector average $1.2B
▼
-79.8% below sector average
Key checks
Key Insights
- In FY2025, cash & equivalents increased 2780.3% year-over-year.
- Ranks #73 out of 148 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.01 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $237.6M | +2780.3% |
| FY2024 | $8.2M | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026